Despite receiving regulatory approval from the ACCC, Verrocchi noted restrictions on discussing detailed growth plans due to merger regulations.

The merger now controls 16% of Australia's pharmacies, totaling 950 locations, which will significantly impact the pharmaceutical retail landscape.

The Gance brothers, who founded Chemist Warehouse in 1972, along with Verrocchi, maintain a 49% stake in the newly merged company, while Chemist Warehouse shareholders hold 85.75% and Sigma shareholders 14.25%.

Future plans for the company include the opening of at least 400 additional stores and exploring potential rebranding of Sigma's pharmacy chains.

On its first day of trading, the company's share price rose 8.3% to $2.99, a significant increase from its December 2023 price of 76.5 cents.

However, the merger has raised concerns from the Pharmacy Guild regarding reduced competition, with fears of non-competitive duopolies and negative impacts on local businesses and patient care.

Chemist Warehouse, co-founded by CEO Mario Verrocchi, successfully launched on the Australian stock exchange on February 13, 2025, following a merger with Sigma Healthcare, creating a $32 billion entity.

The merger's unique franchise model, involving family and friends, allows Chemist Warehouse to circumvent ownership limitations in the pharmacy industry.

Verrocchi expressed pride in the company's journey, emphasizing decades of hard work and resilience, and noted that the merger has created over 100 millionaires, with founders now worth around $2.5 billion each.